Navigation Links
Martek Announces Fourth Quarter and FY 2010 Financial Results
Date:12/8/2010

ectively, was recognized in connection with the Company's ongoing joint development agreement with a subsidiary of BP p.l.c. ("BP") for production of microbial oils for use as biofuels.  Consistent with previous disclosures, as of October 31, 2010, we have effectively ceased all contract manufacturing activities.

Gross Margin and Operating Expenses Overall gross margin for the fourth quarter of fiscal 2010 was 52%, an increase over the 44% gross margin realized in the fourth quarter of fiscal 2009.  For the full year 2010, gross margin was 48%, an increase from the 43% gross margin realized for the full year 2009.  Gross margin improvements were largely due to both ARA and DHA cost reductions and the positive impact of higher gross margins on sales of branded consumer health products.

Research and development (R&D) expenses for the fourth quarter of fiscal 2010 were $9.2 million, or 8% of sales, consistent with previously stated guidance. R&D expenses for the full year increased to $33.6 million, up from $27.4 million in fiscal 2009.  R&D continues to focus on broadening the market applications for life'sDHA through new product and process innovations, as well as leveraging the Company's microbial technology platform to develop new product offerings for its core nutritional markets and new high-value opportunities beyond nutrition.  

Selling, general and administrative (SG&A) expenses for the fourth quarter of fiscal 2010 were $21.6 million, or 18% of sales, consistent with prior guidance.  Full year SG&A expenses increased to $71.2 million, or 16% of sales.  Year-to-year increases in fourth quarter and full year 2010 SG&A expenses are attributable to incremental expenses associated with Amerifit, and to a lesser extent, increases in the variable component of Company-wide compensation resulting from Martek's improved overall financial performance.

Advertising and
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Martek to Present at Upcoming Citi Small / Mid Cap Conference
2. Martek to Present at Upcoming UBS Conference
3. Martek Announces Third Quarter FY 2010 Financial Results
4. Martek Announces Fourth Quarter and FY 2009 Financial Results
5. Martek Signs Sole-Source Supply Agreement with Fonterra
6. Martek to Announce Fourth Quarter and Fiscal Year 2009 Results
7. Martek Announces Addition to Its Board of Directors
8. Martek to Present at Two Upcoming Investor Conferences
9. Martek Announces Settlement of Patent Dispute with Capsugel France
10. Federal Circuit Rules in Marteks Favor in Appeal of Patent Infringement Case
11. Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that ... leading Russian pharmaceutical company, to develop and commercialize nemonoxacin ... , Turkey and other ... novel antibiotic for the treatment of bacterial infections including ...
(Date:1/14/2014)... Carahsoft and CDS Federal Services have scheduled a ... EST (11am PST), “Natural Language Processing: Converting Raw Data ... can turn raw, heterogeneous data into actionable knowledge to ... webinar will last approximately one hour. , Synopsis: Big ...
(Date:1/14/2014)... 2014  3D Communications, a leading provider of strategic communications services to ... events in the United States and ... Cox , JD, is returning to the firm,s Washington, ... 3D after more than two years of service as Associate Commissioner ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Estate Equities, Inc. (NYSE: ARE ), Landlord of ... , today provided an update highlighting recent accomplishments. , ... Pfizer Inc. at the Alexandria Center for Science and ... Pfizer Inc. entered into a 15-year lease for approximately ...
... Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management will present at the 8th ... a.m. Pacific Time. , The conference is being held October 28-29, 2009, at ... with slides and available for replay afterwards. The webcast can be accessed at ... ...
... Ind., Oct. 28 Zimmer Holdings, Inc. (NYSE: ... Grants Association LLC (OMeGA) has chosen its 2009 grant ... administrator for graduate medical education to which Zimmer committed ... 2009-2010 academic year. , OMeGA received more than 250 ...
Cached Biology Technology:Alexandria Real Estate Equities, Inc. Provides Update 2Alexandria Real Estate Equities, Inc. Provides Update 3Alexandria Real Estate Equities, Inc. Provides Update 4Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 2Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 3Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 4
(Date:4/24/2014)... Researchers from North Carolina State University and the University ... new ultrasound device that could help identify arterial plaque ... causing heart attack or stroke. , At issue is ... age. Some types of plaque are deemed "vulnerable," meaning ... artery wall and cause heart attack or stroke. , ...
(Date:4/24/2014)... of clear liquid can bend light, acting as a ... developed a new process to create inexpensive high quality ... , Because they,re so inexpensive, the lenses can ... to detect diseases in the field, scientific research in ... in classrooms. , "What I,m really excited about ...
(Date:4/23/2014)... chronic inflammatory disorders among people of lower socioeconomic status ... to the microbes that thrive in rural environments, according ... in the journal Clinical & Experimental Immunology , ... less access to green spaces may be more apt ... system dysfunction. , When our immune systems are working ...
Breaking Biology News(10 mins):New ultrasound device may add in detecting risk for heart attack, stroke 2Bake your own droplet lens 2Bake your own droplet lens 3Rural microbes could boost city dwellers' health 2Rural microbes could boost city dwellers' health 3
... to over hunting in the 19th century, wild elk ... of the Ontario elk restoration program. According to a ... issue of Restoration Ecology, 460 elk were brought from ... and 2001. , "The Ontario elk restoration program has ...
... Researchers at the University of Illinois at Urbana-Champaign ... optical microscopy that can produce crisp, three-dimensional images ... Aperture Microscopy, ISAM can do for optical microscopy ... resonance, and what computed tomography did for X-ray ...
... gene has been discovered by scientists at the Lundberg Laboratory ... Sahlgrenska Academy in Sweden. The researchers found that women with ... higher risk of contracting breast cancer than expected. , ... for new hereditary breast cancer genes, but thus far few ...
Cached Biology News:Novel computed imaging technique uses blurry images to enhance view 2New hereditary breast cancer gene discovered 2
... Kit uses a simplified procedure and streamlines ... The kit is based on the three ... and sodium bisulfite where cytosine is converted ... innovative in-column desulphonation reaction eliminates several precipitation ...
... The DIGIVIEW line of digital x-ray ... radiation imaging device complete with 12 to ... area consists of a photodiode array sensor ... All models are available in low x-ray ...
Metamine is an autonomous data mining tool that extends the capabilities of conventional research teams. It is a proactive agent that searches for significant results buried within the GeNet data rep...
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selecitivty and potential CNS-Side Effect liabilities of compo...
Biology Products: